Co-Processing Technology

OPACT® SMCC 50 is a silicified microcrystalline cellulose excipient made of 98% MCC and 2% colloidal silicon dioxide by co-processing. It delivers excellent compressibility and good flowability for direct compression and dry granulation in oral solid dosage forms.

OPACT® SMCC 90 is a silicified microcrystalline cellulose excipient combining 98% MCC with 2% colloidal silicon dioxide. It offers the optimal balance of flowability and compressibility for direct compression and dry granulation in oral solid dosage forms.

OPACT® DMCC 25 is a co-processed excipient composed of mannitol, microcrystalline cellulose, and silicon dioxide. Designed for pharmaceutical and health food applications, it is specifically engineered to support the formulation and production of orally disintegrating tablets.

OPACT® DMCC 30 is a novel co-processed pharmaceutical excipient composed of mannitol, microcrystalline cellulose, crospovidone, and colloidal silicon dioxide. It is specifically engineered for oral fast-disintegrating tablets, ensuring rapid disintegration and a pleasant mouthfeel.

OPACT® MCPP​ is Westpoint's co-processed direct compression premix composed of D-mannitol, crospovidone, polyvinyl acetate, and povidone. Engineered for orally disintegrating tablets (ODTs), it combines filling, binding, and disintegrating functions in one free-flowing powder — enabling simple blending with APIs and lubricants for direct tableting.

OPACT® LMCC is a co-processed pharmaceutical excipient composed of 75% alpha-lactose monohydrate and 25% microcrystalline cellulose, specifically designed for direct compression as a high-performance filler and binder in tablets, capsules, and granules.

OPACT® LPCC is a co-processed pharmaceutical excipient combining lactose and powdered cellulose. It offers excellent compressibility, flowability, and disintegration, serving as a versatile multifunctional filler and binder for solid dosage formulations.

OPACT® LPC is a co-processed pharmaceutical excipient combining lactose monohydrate, povidone, and crospovidone into a single free-flowing premix. Engineered for direct compression and hard capsule filling, it integrates filler, binder, and disintegrant functions in one standardized system, helping pharmaceutical manufacturers streamline formulation and accelerate tablet production.

OPACT® Starch Lactose is a co‑processed direct compression excipient manufactured by spray‑drying a composite of approximately 85% α‑lactose monohydrate and 15% maize starch. It is specifically designed for tablet and capsule formulation, providing excellent flowability, superior compressibility, and rapid disintegration independent of tablet hardness.

OPACT® Cornstarch Mannitol is a co-processed pharmaceutical excipient manufactured by spray drying approximately 80% mannitol with 20% corn starch. It is designed as a direct-compression filler for orally disintegrating tablets and chewable tablets, delivering excellent powder flow, compressibility, and rapid disintegration.